Medicare Part D drug tiers, explained
Photo: RDNE Stock project on Pexels
Your pharmacist mentions your drug has moved to a "non-preferred" tier, or a new prescription lands on the specialty tier, and you have no idea what either means for your wallet. Medicare Part D sorts every covered drug into a numbered tier, and that number decides your copay or coinsurance, whether prior authorization applies, and how hard it is to get an exception. This guide breaks down what tiers 1 through 5 typically cover, what changes as a drug climbs the ladder, and how the numbers translate into real restrictions, using the newest published data on specialty-tier cost-sharing.
Key takeaways
- Most Part D formularies use five tiers, running from preferred generic (tier 1, cheapest) to specialty (tier 5, most expensive).
- Tier numbers aren't standardised across plans: a drug on tier 2 with one insurer can sit on tier 3 with another.
- Cost-sharing typically shifts from a flat, low copay on tiers 1-2 to coinsurance (a percentage of the drug's cost) from tier 3 upward.
- Prior authorization and step therapy show up far more often on non-preferred and specialty drugs than on preferred generics.
- Median coinsurance for specialty-tier drugs was 28% for Medicare Advantage prescription drug plan enrollees versus 25% for standalone plan enrollees in 2026, per KFF.
- A tiering exception can move a drug to a cheaper tier, but this route generally isn't available for drugs already on the specialty tier.
What a drug tier actually is
A formulary is a payer's drug list, and a tier is the shelf that list assigns each drug to. Every covered medicine sits on exactly one tier, and that placement, not the drug's chemical name or how serious your condition is, decides two things: how much you pay at the counter, and how much scrutiny the plan applies before it pays its share. Lower tiers hold cheaper, heavily preferred drugs; higher tiers hold pricier brand names, drugs with generic rivals, and the costliest specialty medicines.
The five tiers most Part D plans use
Formularies vary between insurers, but the pattern is remarkably consistent. Most Medicare Part D plans, whether standalone prescription drug plans or the drug portion of a Medicare Advantage plan, organise their formulary into five tiers running from cheapest to most expensive.
| Tier | Typical drug type | Typical restrictions | Typical cost-sharing pattern |
|---|---|---|---|
| 1 — Preferred generic | Lower-cost, commonly used generics | Rare; sometimes a quantity limit | The lowest fixed copay the plan offers, occasionally $0 |
| 2 — Generic | Other generic drugs not on tier 1 | Uncommon; occasional quantity limit | A modest, still-fixed copay above tier 1 |
| 3 — Preferred brand | Brand-name drugs without a preferred generic equivalent | Step therapy appears here more often than on tiers 1-2 | A higher fixed copay, or the point where some plans switch to coinsurance |
| 4 — Non-preferred drug | Higher-cost generics and brand drugs with a preferred alternative | Prior authorization and step therapy both become common | Typically coinsurance (a percentage of cost) rather than a flat copay |
| 5 — Specialty | High-cost drugs for complex conditions (biologics, some cancer and immune therapies) | Prior authorization is the norm, often alongside other management | The plan's highest coinsurance rate; see the verified figures below |
Some plans compress this into four tiers, or split tier 4 further; a handful use six. But five tiers, in roughly this order, is what you'll meet on the large majority of 2026 Part D formularies.
Why your tier 3 might be someone else's tier 2
Here's the catch that trips people up more than any other: tier numbers are not standardised across plans. Each insurer builds and files its own formulary with Medicare, and it alone decides which drugs count as "preferred" in each category. A statin that lands on tier 1 with one insurer might sit on tier 2 with another, simply because that plan negotiated a different rebate or struck a different deal with the manufacturer. The tier number tells you where a drug sits *within your specific plan*. It says nothing about where that same drug sits on a neighbour's plan, even if you're both enrolled in Medicare Part D.
How cost-sharing climbs tier by tier
The broad shape holds across nearly every formulary, even where the exact figures don't. Tier 1 typically carries the lowest fixed copay a plan offers, sometimes nothing at all. Tier 2 usually asks for a slightly higher, but still fixed, copay. From tier 3 upward, many plans stop using a flat copay altogether and switch to coinsurance, a percentage of the drug's cost rather than a set dollar figure, which is what makes the top tiers so much harder to budget for. Specialty tier, sitting at the top, is where that shift matters most, and it's the one part of the tier system with a solid, current statistic behind it.
“Median coinsurance for specialty tier drugs (those that cost over $950 in 2026) is higher for MA-PD enrollees than PDP enrollees—28% vs. 25%.”
That gap between Medicare Advantage prescription drug enrollees and standalone plan enrollees, 28% versus 25%, is itself a reminder that even within "specialty tier," the exact cost-sharing depends on which plan you hold. Plans that waive some or all of the standard deductible, which most Medicare Advantage prescription drug plans do, are permitted to set that coinsurance rate above 25%, which is part of why the median comes out higher for that group.
Restrictions climb with the tiers too
Cost isn't the only thing that increases as a drug moves up the list. Prior authorization and step therapy cluster far more heavily on non-preferred and specialty drugs than on preferred generics, since those are the expensive medicines an insurer most wants a prescriber to justify before it pays out. A tier 1 generic is unlikely to carry any restriction beyond a quantity limit. A tier 5 specialty biologic, by contrast, will very often need prior authorization, and sometimes proof that a cheaper option has already been tried and failed.
A drug moving tiers mid-year: a worked example
Here's an illustrative example, not a real patient, of how a tier change plays out in practice. Say a plan places a widely used cholesterol drug on tier 2 in January, alongside the other generics at a fixed, low copay. Partway through the year, the manufacturer of a closely related brand renegotiates its rebate terms, and the insurer reclassifies the generic onto tier 3 as part of a formulary update. Nothing about the prescription itself has changed: same drug, same dose. But the plan now treats it as a non-preferred product. The patient's copay rises from a flat few dollars to a noticeably higher flat amount, or a percentage of cost, and a step-therapy flag may now sit alongside it that wasn't there before. The only notice most people get is a letter from the plan, or a surprise at the pharmacy counter, unless they'd been checking the formulary directly.
Asking for a tier exception
If a drug's tier is pushing your cost higher than a lower-tier alternative would, your prescriber can request a tiering exception on your behalf: a formal ask for the plan to cover that specific drug at a lower cost-sharing level. Broadly, the process runs like this:
- Your prescriber submits a statement explaining why the lower-tier alternatives on the formulary aren't suitable for you.
- The plan reviews the request against its own tiering-exception criteria, generally on the same 72-hour (standard) or 24-hour (expedited) clock as any other coverage determination.
- If approved, you pay the lower tier's cost-sharing for that specific drug for the rest of the plan year, or until the formulary changes again.
- If refused, you can appeal the decision the same way you'd appeal any other coverage determination.
One limit worth knowing upfront: this route is typically not available for a drug that's already on the specialty tier, since Medicare treats requests to lower cost-sharing on non-specialty drugs differently from the specialty tier itself.
Common misconceptions about drug tiers
- Assuming tier numbers mean the same thing on every plan. Each formulary sets its own tier assignments, so a "tier 2" drug on one plan can be a "tier 3" drug on another, with no dollar figure attached to the number itself.
- Assuming specialty tier automatically means "not covered." Specialty tier is a cost-sharing category, not a rejection. The drug is covered, just at the highest cost-sharing level, and often only once prior authorization or another requirement is met.
- Assuming a drug's tier is fixed for the whole plan year. Insurers can move drugs between tiers, or add restrictions, during the year with notice, so a drug that was tier 2 in January can be tier 3 by autumn.
- Assuming a tiering exception can always lower a specialty-tier drug's cost-sharing. Most plans don't allow that particular route, since tiering exceptions are generally reserved for moving a non-specialty drug down a tier.
- Assuming the tier number reflects how medically necessary a drug is. It reflects cost and preferred status, not clinical importance, which is exactly why a separate formulary exception process exists for a drug that isn't listed at all.
Frequently asked questions
What is a Medicare Part D drug tier?
A tier is the cost-sharing category a formulary places a drug in, generally numbered 1 (cheapest) to 5 (most expensive, specialty). It sets your copay or coinsurance and which restrictions, such as prior authorization, apply.
What are the drug tiers in Medicare Part D?
Most plans use five: tier 1 preferred generic, tier 2 generic, tier 3 preferred brand, tier 4 non-preferred drug, and tier 5 specialty. Some formularies compress or expand this, so it's worth checking your own plan's tier list directly.
What tier is tier 3 in Medicare Part D?
Tier 3 is usually "preferred brand": brand-name drugs without a lower-cost generic equivalent that the plan has chosen to favour over other brands in the same class. Confirm this on your own plan's formulary, since tier numbering isn't standardised across insurers.
Does a higher tier always mean I need prior authorization?
Not always, but restrictions such as prior authorization and step therapy cluster on non-preferred and specialty tiers far more than on preferred generics, largely because those are the more expensive drugs a plan wants reviewed first.
Can I get a drug moved to a cheaper tier?
Yes, through a tiering exception, if your prescriber shows the preferred alternatives on that lower tier wouldn't work as well for you or would cause problems specific to your case. This route is generally not available for drugs already on the specialty tier itself.
Related on Benefily
Administrative information only. Benefily reports what a payer has published in its own prior-authorization policy as of the effective date shown. It is not medical advice, not a coverage or payment guarantee, and not an authorization. Requirements vary by plan, place of service and member benefits — always verify with the payer before rendering service.
More from Academy
Does Medicare Cover Ozempic? The Honest Answer
Does Medicare cover Ozempic? Yes for type 2 diabetes, subject to plan-specific prior authorization — almost never for weight loss alone under Part D.
Prior Authorization Denied? What to Do Next
Prior authorization denied for your Medicare Part D drug? Here's the appeal ladder, the deadlines, and why appealing is usually worth it.
Step Therapy Explained: What It Means and What to Do Next
What is step therapy? A practical guide to how it works in Medicare Part D, what your prescriber must submit, and how to avoid common mistakes.